The Abstinence Clearinghouse Blog

            Researchers with the Federal Vaccine Adverse Events Reporting System have reported that Gardasil, marketed by Merck and touted as a preventive against strains of human papillomavirus that cause cervical cancer, has a 400 per cent higher rate of adverse effects than another comparable vaccine, the Menactra anti-meningitis shot.

            Gardasil is associated with twice as many emergency room visits, four times as many deaths, four times as many heart attacks, seven times as many “disabled” reports and fifteen times as many strokes when compared to Menactra, manufactured by GlaxoSmithKline.  All reported cases of blood clots and heart attacks associated with Gardasil occurred when the vaccine was given alone, not in conjunction with other drugs.

            Researchers compared Gardasil and Menactra because they are given to similar age groups at similar frequencies.  Gardasil has been promoted for use by girls as young as nine years old through national advertising campaigns.

            The report recommends that the government more thoroughly investigate reports of dangerous side effects from the HPV vaccine and that parents be more adequately warned of the risks before vaccination.

            In also recommends that Congress investigate how the vaccine was fast-tracked for approval in the absence of safety data on girls younger than 17.

Source:  Natural News